Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 163

1.

Prevention of Cardiovascular Disease by the Reduction of Glycemic Exposure in Type 2 Diabetes: A Perspective on Glucose-Lowering Interventions.

Roussel R, Steg PG, Mohammedi K, Marre M, Potier L.

Diabetes Obes Metab. 2017 Jun 9. doi: 10.1111/dom.13033. [Epub ahead of print] Review.

PMID:
28597588
2.

REPEATED MEASUREMENTS OF BLOOD PRESSURE AND CHOLESTEROL IMPROVES CARDIOVASCULAR DISEASE RISK PREDICTION: AN INDIVIDUAL-PARTICIPANT-DATA META-ANALYSIS.

Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E, Gudnason V, Nordestgaard BG, Psaty BM, Goldbourt U, Best LG, Assmann G, Salonen JT, Nietert PJ, Verschuren WM, Brunner EJ, Kronmal RA, Salomaa V, Bakker SJ, Dagenais GR, Sato S, Jansson JH, Willeit J, Onat A, de la Cámara AG, Roussel R, Völzke H, Dankner R, Tipping RW, Meade TW, Donfrancesco C, Kuller LH, Peters A, Gallacher J, Kromhout D, Iso H, Knuiman M, Casiglia E, Kavousi M, Palmieri L, Sundström J, Davis BR, Njølstad I, Couper D, Danesh J, Thompson SG, Wood A.

Am J Epidemiol. 2017 May 26. doi: 10.1093/aje/kwx149. [Epub ahead of print]

PMID:
28549073
3.

Urinary lysophopholipids are increased in diabetic patients with nephropathy.

Saulnier-Blache JS, Feigerlova E, Halimi JM, Gourdy P, Roussel R, Guerci B, Dupuy A, Bertrand-Michel J, Bascands JL, Hadjadj S, Schanstra JP.

J Diabetes Complications. 2017 Jul;31(7):1103-1108. doi: 10.1016/j.jdiacomp.2017.04.024. Epub 2017 May 10.

PMID:
28506691
4.

T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.

Nicolas A, Mohammedi K, Bastard JP, Fellahi S, Bellili-Muñoz N, Roussel R, Hadjadj S, Marre M, Velho G, Fumeron F.

Nephrol Dial Transplant. 2017 May 12. doi: 10.1093/ndt/gfx071. [Epub ahead of print]

PMID:
28499019
5.

Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.

El Boustany R, Taveau C, Chollet C, Velho G, Bankir L, Alhenc-Gelas F, Roussel R, Bouby N.

J Diabetes Complications. 2017 Jun;31(6):929-932. doi: 10.1016/j.jdiacomp.2017.04.005. Epub 2017 Apr 6.

PMID:
28412033
6.

Vasopressin and diabetic nephropathy.

Roussel R, Velho G, Bankir L.

Curr Opin Nephrol Hypertens. 2017 Jul;26(4):311-318. doi: 10.1097/MNH.0000000000000335.

PMID:
28403013
7.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk.

Potier L, Roussel R, Elbez Y, Marre M, Zeymer U, Reid CM, Ohman M, Eagle KA, Bhatt DL, Steg PG; REACH Registry Investigators*.

Heart. 2017 Mar 11. pii: heartjnl-2016-310705. doi: 10.1136/heartjnl-2016-310705. [Epub ahead of print]

PMID:
28285267
8.

Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population.

Saulnier PJ, Gand E, Ragot S, Bankir L, Piguel X, Fumeron F, Rigalleau V, Halimi JM, Marechaud R, Roussel R, Hadjadj S, Study Group S.

J Diabetes Res. 2017;2017:5327352. doi: 10.1155/2017/5327352. Epub 2017 Feb 1.

9.

Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans.

Wigger L, Cruciani-Guglielmacci C, Nicolas A, Denom J, Fernandez N, Fumeron F, Marques-Vidal P, Ktorza A, Kramer W, Schulte A, Le Stunff H, Liechti R, Xenarios I, Vollenweider P, Waeber G, Uphues I, Roussel R, Magnan C, Ibberson M, Thorens B.

Cell Rep. 2017 Feb 28;18(9):2269-2279. doi: 10.1016/j.celrep.2017.02.019.

10.

Relationship between salivary/pancreatic amylase and body mass index: a systems biology approach.

Bonnefond A, Yengo L, Dechaume A, Canouil M, Castelain M, Roger E, Allegaert F, Caiazzo R, Raverdy V, Pigeyre M, Arredouani A, Borys JM, Lévy-Marchal C, Weill J, Roussel R, Balkau B, Marre M, Pattou F, Brousseau T, Froguel P.

BMC Med. 2017 Feb 23;15(1):37. doi: 10.1186/s12916-017-0784-x.

11.

Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes.

Moutairou A, Roussel R, Charbonnel B, Leye A, Detournay B, Mohammedi K, Potier L.

Diabetes Metab. 2017 Feb 1. pii: S1262-3636(16)30572-9. doi: 10.1016/j.diabet.2016.11.009. [Epub ahead of print] No abstract available.

PMID:
28161368
12.

Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V1A receptors.

Taveau C, Chollet C, Bichet DG, Velho G, Guillon G, Corbani M, Roussel R, Bankir L, Melander O, Bouby N.

Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E127-E135. doi: 10.1152/ajpendo.00269.2016. Epub 2016 Dec 20.

PMID:
27998960
13.

Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.

Saulnier PJ, Gand E, Velho G, Mohammedi K, Zaoui P, Fraty M, Halimi JM, Roussel R, Ragot S, Hadjadj S; SURDIAGENE Study Group.

Diabetes Care. 2017 Mar;40(3):367-374. doi: 10.2337/dc16-1571. Epub 2016 Dec 20.

PMID:
27998909
14.

Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.

Bonnet F, Gastaldelli A, Pihan-Le Bars F, Natali A, Roussel R, Petrie J, Tichet J, Marre M, Fromenty B, Balkau B; D.E.S.I.R., RISC Study Groups.

J Hypertens. 2017 Mar;35(3):493-500. doi: 10.1097/HJH.0000000000001204.

PMID:
27984413
15.

Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

Pacheco Y, Calender A, Israël-Biet D, Roy P, Lebecque S, Cottin V, Bouvry D, Nunes H, Sève P, Pérard L, Devouassoux G, Freymond N, Khouatra C, Wallaert B, Lamy R, Elsensohn MH, Bardel C, Valeyre D; GSF group.

Orphanet J Rare Dis. 2016 Dec 3;11(1):165.

16.

Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.

Velho G, El Boustany R, Lefèvre G, Mohammedi K, Fumeron F, Potier L, Bankir L, Bouby N, Hadjadj S, Marre M, Roussel R.

Diabetes Care. 2016 Dec;39(12):2288-2295. Epub 2016 Oct 11.

PMID:
27729425
17.

Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling.

Yengo L, Arredouani A, Marre M, Roussel R, Vaxillaire M, Falchi M, Haoudi A, Tichet J; D.E.S.I.R Study Group, Balkau B, Bonnefond A, Froguel P.

Mol Metab. 2016 Aug 23;5(10):918-25. doi: 10.1016/j.molmet.2016.08.011. eCollection 2016 Oct.

18.

Gene Polymorphisms of FABP2, ADIPOQ and ANP and Risk of Hypertriglyceridemia and Metabolic Syndrome in Afro-Caribbeans.

Larifla L, Rambhojan C, Joannes MO, Maimaitiming-Madani S, Donnet JP, Marianne-Pépin T, Chout R, Roussel R, Foucan L.

PLoS One. 2016 Sep 29;11(9):e0163421. doi: 10.1371/journal.pone.0163421. eCollection 2016.

19.

Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.

Hansel B, Bonnefont-Rousselot D, Orsoni A, Bittar R, Giral P, Roussel R, Marre M, Mohammedi K, Bruckert E, Chapman MJ, Kontush A.

J Clin Lipidol. 2016 Sep-Oct;10(5):1172-81. doi: 10.1016/j.jacl.2016.05.008. Epub 2016 May 14.

PMID:
27678434
20.

Short-term effect of severe hypoglycaemia on glycaemic control in the Diabetes Control and Complications Trial.

Moutairou A, Roussel R, Charbonnel B, El Boustany R, Nicolas A, Leye A, Mohammedi K, Marre M, Detournay B, Potier L.

Diabetes Metab. 2017 Apr;43(2):187-190. doi: 10.1016/j.diabet.2016.08.001. Epub 2016 Sep 21. No abstract available.

PMID:
27665052

Supplemental Content

Loading ...
Support Center